Yeşim ALTAY, Özgür BALTA, Sema TAMER, Ayşe BURCU

Amniotic membrane transplantation in bacterial and herpetic stromal keratitis

Background/aim: The aim of this study was to describe the results of amniotic membrane transplantation (AMT) in patients with bacterial and herpetic stromal keratitis. Materials and methods: This was a retrospective chart review study including 42 patients with herpetic keratitis (group 1) and 42 patients with bacterial keratitis (group 2). AMT was performed in addition to antimicrobial therapy. Topical steroids were administered after surgery. The outcome parameters evaluated were epithelialization time, decrease of stromal inflammation, and uncorrected visual acuity (UCVA). Results: The average age of our patients was 55.85 ± 19.07 years, and average follow-up was 14.70 ± 11.75 months. The period of epithelialization was 19.23 ± 7.32 days in the herpetic group and 19.31 ± 6.30 days in the bacterial group. Descemetocele developed in 2 patients of the herpetic group. Other patients in both groups completed epithelialization after AMT procedures with varying amounts of corneal scarring. The bacterial group showed an improvement in UCVA, but the herpetic group showed no improvement in UCVA. Conclusion: AMT is a convenient approach for the treatment of corneal keratitis resistant to conventional treatment and allows the use of early topical steroid application. It provides patients with corneal scarring an opportunity for subsequent keratoplasty by arresting the inflammatory response.

PDF

___

1. Edelstein SL, Wichiensin P, Huang AJW. Bacterial keratitis. In: Krachmer JH, Mannis M, Holland EJ, editors. Cornea Fundamentals, Diagnosis and Management. Volume 1-A. 3rd ed. Beijing, China: Mosby Elsevier; 2010. pp. 919944.
2. Kreger AS. Pathogenesis of Pseudomonas aeruginosa ocular diseases. Rev Infect Dis 1983; 5: S931S935.
3. Shi W, Chen M, Xie L. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis. Ophthalmol 2007; 114: 1476 1481.
4. Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence based review. Surv Ophthalmol 2009; 54: 226234.
5. Gangopadhyay N, Daniell M, Weih L, Taylor HR. Fluoroquinolone and fortified antibiotics for treating bacterial and corneal ulcers. Br J Ophthalmol 2000; 84: 378384.
6. Gicquel JJ, Bejjani RA, Ellies P, Mercie M, Dighiero P. Amniotic membrane transplantation in severe bacterial keratitis. Cornea 2007; 26: 2733.
7. Kheirkhah A, Tabatabaei A, Zavareh MK, Khodabandeh A. A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis. Can J Ophthalmol 2012; 47: 305 311.
8. Heiligenhaus A, Li H, Hernandez Galindo EE, Koch JM, Steuhl KP, Meller D. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol 2003; 87: 12151219.
9. Brijacak N, Dekaris I, Gagro A, Gabric N. Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis. Coll Antropol 2008; 32: 2125.
10. Lee S, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123: 303312.
11. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol 1999; 83: 748752.
12. Khokhar S, Natung T, Sony P, Sharma N, Agarwal N, Vajpayee R. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized controlled trial. Cornea 2005; 24: 654660.
13. Dua HS, Gomes JAP, King AJ, Maharajan SV. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004; 49: 51 77.
14. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000; 19: 348352.
15. Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocul Surf 2004; 2: 201211.
16. Yildiz EH, Nurozler AB, Aksoy NO, Altiparmak UE, Onat M, Karaguzel H, Duman S. Amniotic membrane transplantation: Indications and results. Eur J Ophthalmol 2008; 18: 685690.
17. Espana EM, Grueterich M, Sandoval H, Solomon A, Alfonso E, Carp CL, Fantes F, Tseng SC. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg 2003; 29: 279284.
18. Wang MX, Gray TB, Park WC, Prabhasawat P, Culbertson W, Forster R, Hanna K, Tseng SCG. Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits. J Cataract Refract Surg 2001; 27: 310 319.
19. Touhami A, Grueterich M, Tseng SC. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci 2002; 43: 987994.
20. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits protease activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 70: 329337.
21. Rodriquez-Ares MT, Tourino R, Lopez-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea 2004; 23: 577583.
22. Kjaaergaard N, Hein M, Hyttel L, Helmig RB, Schonheyder HC, Uldbjerg N, Madsen H. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001; 94: 224229.
23. Paradowska E, Blach-Olszewska Z, Sender J, Jaroz W. Antiviral nonspecific immunity of human placenta at term: possible role of endogenous tumor necrosis factors and interferons. J Interferon Cytokine Res 1996; 16: 941948.
24. Resch MD, Resch BE, Csizmazia E, Imre L, Nemeth J, SzaboRevesz P, Csanyi E. Drug reservoir function of human amniotic membrane. J Ocular Pharma Therapeutics 2011; 27: 323326.